Information  X 
Enter a valid email address

Citigroup GM Fdg Lux (IRSH)

  Print      Mail a friend

Friday 31 July, 2020

Citigroup GM Fdg Lux

Article 17

RNS Number : 8257U
Citigroup Global Markets Fdg Lux
31 July 2020
 

30 July 2020

NOTICE

pursuant to the Final Terms dated 14 May 2020 as amended and restated by the Amended and Restated Final Terms dated 27 July 2020 and the Amended and Restated Final Terms dated 30 July 2020 (the Final Terms)

relating to

Citigroup Global Markets Funding Luxembourg S.C.A.

Issue of up to EUR20,000,000 Citigroup Global Markets Funding Luxembourg S.C.A. (LU) Global Equities Bonus Note 2030

 

Guaranteed by Citigroup Global Markets Limited

Under the Citi U.S.$60,000,000,000 Global Medium Term Note Programme

 

(Series Number: CGMFL13570 , ISIN: XS2137896275 )

 

The Issuer hereby provides notice in accordance with the Final Terms that:

(a)  the final Aggregate Principal Amount of the Notes to be issued on 31 July 2020 will be EUR6,990,000;

(b)  the title of the Notes is now "Issue of EUR6,990,000 Citigroup Global Markets Funding Luxembourg S.C.A. (LU) Global Equities Bonus Note 2030"; and

(c)  the final distribution fee payable to the Authorised Offeror in respect of the Notes to be issued on 31 July 2020 will be 4.50 per cent. of the Aggregate Principal Amount.

 

Capitalised terms used but not defined herein shall be as defined in the Final Terms.

 

This Notice and the Final Terms shall be read and construed together as one document.

 

 

 

Signed on behalf of Citigroup Global Markets Funding Luxembourg S.C.A.

 

 

 

By:….

Duly authorised

 

This announcement has been issued through the Companies Announcement Service of Euronext Dublin.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISERBMATMTBJBTM

a d v e r t i s e m e n t